S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in
NASDAQ:WMGI

Wright Medical Group Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.
$29.98
0.00 (0.00 %)
(As of 11/11/2020)
Add
Compare
Today's Range
$29.98
Now: $29.98
$29.98
50-Day Range
$29.98
MA: $30.23
$30.72
52-Week Range
$23.14
Now: $29.98
$30.74
Volume9,689 shs
Average Volume2.02 million shs
Market Capitalization$3.90 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.57

Competitors

Wright Medical Group (NASDAQ:WMGI) Vs. ABT, MDT, SYK, ISRG, BDX, and EW

Should you be buying WMGI stock or one of its competitors? Companies in the sub-industry of "health care equipment" are considered alternatives and competitors to Wright Medical Group, including Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), and Edwards Lifesciences (EW).

Wright Medical Group (NASDAQ:WMGI) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Valuation and Earnings

This table compares Wright Medical Group and Abbott Laboratories' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wright Medical Group$920.90 million4.23$-114,220,000.00$0.06499.67
Abbott Laboratories$31.90 billion6.37$3.69 billion$3.2435.41

Abbott Laboratories has higher revenue and earnings than Wright Medical Group. Abbott Laboratories is trading at a lower price-to-earnings ratio than Wright Medical Group, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Wright Medical Group has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Wright Medical Group and Abbott Laboratories, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wright Medical Group02002.00
Abbott Laboratories121302.75

Wright Medical Group currently has a consensus price target of $30.00, indicating a potential upside of 0.07%. Abbott Laboratories has a consensus price target of $115.6875, indicating a potential upside of 0.84%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Abbott Laboratories is more favorable than Wright Medical Group.

Insider and Institutional Ownership

72.6% of Abbott Laboratories shares are held by institutional investors. 4.1% of Wright Medical Group shares are held by insiders. Comparatively, 1.7% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Wright Medical Group and Abbott Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Wright Medical Group-16.59%-3.86%-1.32%
Abbott Laboratories10.50%18.19%8.29%

Summary

Abbott Laboratories beats Wright Medical Group on 13 of the 14 factors compared between the two stocks.

Medtronic (NYSE:MDT) and Wright Medical Group (NASDAQ:WMGI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.

Risk & Volatility

Medtronic has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Wright Medical Group has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Medtronic and Wright Medical Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medtronic032012.92
Wright Medical Group02002.00

Medtronic currently has a consensus target price of $122.2963, indicating a potential upside of 4.62%. Wright Medical Group has a consensus target price of $30.00, indicating a potential upside of 0.07%. Given Medtronic's stronger consensus rating and higher possible upside, research analysts clearly believe Medtronic is more favorable than Wright Medical Group.

Profitability

This table compares Medtronic and Wright Medical Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medtronic12.69%9.71%5.30%
Wright Medical Group-16.59%-3.86%-1.32%

Institutional & Insider Ownership

79.2% of Medtronic shares are owned by institutional investors. 0.5% of Medtronic shares are owned by insiders. Comparatively, 4.1% of Wright Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Medtronic and Wright Medical Group's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$28.91 billion5.44$4.79 billion$4.5925.47
Wright Medical Group$920.90 million4.23$-114,220,000.00$0.06499.67

Medtronic has higher revenue and earnings than Wright Medical Group. Medtronic is trading at a lower price-to-earnings ratio than Wright Medical Group, indicating that it is currently the more affordable of the two stocks.

Summary

Medtronic beats Wright Medical Group on 14 of the 15 factors compared between the two stocks.

Wright Medical Group (NASDAQ:WMGI) and Stryker (NYSE:SYK) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Profitability

This table compares Wright Medical Group and Stryker's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Wright Medical Group-16.59%-3.86%-1.32%
Stryker12.35%20.94%8.77%

Analyst Ratings

This is a breakdown of recent recommendations for Wright Medical Group and Stryker, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wright Medical Group02002.00
Stryker271412.58

Wright Medical Group currently has a consensus target price of $30.00, indicating a potential upside of 0.07%. Stryker has a consensus target price of $227.4783, indicating a potential downside of 5.04%. Given Wright Medical Group's higher possible upside, equities analysts plainly believe Wright Medical Group is more favorable than Stryker.

Risk and Volatility

Wright Medical Group has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500.

Insider and Institutional Ownership

71.5% of Stryker shares are held by institutional investors. 4.1% of Wright Medical Group shares are held by insiders. Comparatively, 6.8% of Stryker shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Wright Medical Group and Stryker's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wright Medical Group$920.90 million4.23$-114,220,000.00$0.06499.67
Stryker$14.88 billion6.05$2.08 billion$8.2629.00

Stryker has higher revenue and earnings than Wright Medical Group. Stryker is trading at a lower price-to-earnings ratio than Wright Medical Group, indicating that it is currently the more affordable of the two stocks.

Summary

Stryker beats Wright Medical Group on 14 of the 15 factors compared between the two stocks.

Intuitive Surgical (NASDAQ:ISRG) and Wright Medical Group (NASDAQ:WMGI) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Valuation & Earnings

This table compares Intuitive Surgical and Wright Medical Group's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$4.48 billion19.74$1.38 billion$9.9575.58
Wright Medical Group$920.90 million4.23$-114,220,000.00$0.06499.67

Intuitive Surgical has higher revenue and earnings than Wright Medical Group. Intuitive Surgical is trading at a lower price-to-earnings ratio than Wright Medical Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Intuitive Surgical and Wright Medical Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Intuitive Surgical24.45%12.08%10.44%
Wright Medical Group-16.59%-3.86%-1.32%

Volatility & Risk

Intuitive Surgical has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Comparatively, Wright Medical Group has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Intuitive Surgical and Wright Medical Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Intuitive Surgical381002.33
Wright Medical Group02002.00

Intuitive Surgical presently has a consensus price target of $736.0588, indicating a potential downside of 2.12%. Wright Medical Group has a consensus price target of $30.00, indicating a potential upside of 0.07%. Given Wright Medical Group's higher possible upside, analysts plainly believe Wright Medical Group is more favorable than Intuitive Surgical.

Insider and Institutional Ownership

86.5% of Intuitive Surgical shares are held by institutional investors. 1.6% of Intuitive Surgical shares are held by company insiders. Comparatively, 4.1% of Wright Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Intuitive Surgical beats Wright Medical Group on 12 of the 14 factors compared between the two stocks.

Becton, Dickinson and (NYSE:BDX) and Wright Medical Group (NASDAQ:WMGI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Profitability

This table compares Becton, Dickinson and and Wright Medical Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Becton, Dickinson and5.11%13.30%5.60%
Wright Medical Group-16.59%-3.86%-1.32%

Insider and Institutional Ownership

83.2% of Becton, Dickinson and shares are owned by institutional investors. 0.8% of Becton, Dickinson and shares are owned by insiders. Comparatively, 4.1% of Wright Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Becton, Dickinson and has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, Wright Medical Group has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.

Earnings & Valuation

This table compares Becton, Dickinson and and Wright Medical Group's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and$17.12 billion4.42$874 million$10.2025.51
Wright Medical Group$920.90 million4.23$-114,220,000.00$0.06499.67

Becton, Dickinson and has higher revenue and earnings than Wright Medical Group. Becton, Dickinson and is trading at a lower price-to-earnings ratio than Wright Medical Group, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and price targets for Becton, Dickinson and and Wright Medical Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Becton, Dickinson and07702.50
Wright Medical Group02002.00

Becton, Dickinson and currently has a consensus price target of $279.6667, indicating a potential upside of 7.46%. Wright Medical Group has a consensus price target of $30.00, indicating a potential upside of 0.07%. Given Becton, Dickinson and's stronger consensus rating and higher possible upside, research analysts clearly believe Becton, Dickinson and is more favorable than Wright Medical Group.

Summary

Becton, Dickinson and beats Wright Medical Group on 13 of the 14 factors compared between the two stocks.

Edwards Lifesciences (NYSE:EW) and Wright Medical Group (NASDAQ:WMGI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

Valuation & Earnings

This table compares Edwards Lifesciences and Wright Medical Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$4.35 billion12.31$1.05 billion$1.8646.18
Wright Medical Group$920.90 million4.23$-114,220,000.00$0.06499.67

Edwards Lifesciences has higher revenue and earnings than Wright Medical Group. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Wright Medical Group, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings for Edwards Lifesciences and Wright Medical Group, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Edwards Lifesciences271202.48
Wright Medical Group02002.00

Edwards Lifesciences currently has a consensus target price of $90.8704, indicating a potential upside of 5.80%. Wright Medical Group has a consensus target price of $30.00, indicating a potential upside of 0.07%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Edwards Lifesciences is more favorable than Wright Medical Group.

Institutional and Insider Ownership

80.9% of Edwards Lifesciences shares are owned by institutional investors. 1.5% of Edwards Lifesciences shares are owned by insiders. Comparatively, 4.1% of Wright Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Edwards Lifesciences has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Wright Medical Group has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

Profitability

This table compares Edwards Lifesciences and Wright Medical Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Edwards Lifesciences18.18%29.00%18.10%
Wright Medical Group-16.59%-3.86%-1.32%

Summary

Edwards Lifesciences beats Wright Medical Group on 13 of the 14 factors compared between the two stocks.


Wright Medical Group Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Abbott Laboratories logo
ABT
Abbott Laboratories
2.4$114.72flat$203.33 billion$31.90 billion60.70Upcoming Earnings
Medtronic logo
MDT
Medtronic
2.7$116.90flat$157.35 billion$28.91 billion44.62
Stryker logo
SYK
Stryker
2.0$239.55flat$90.02 billion$14.88 billion51.96Upcoming Earnings
Intuitive Surgical logo
ISRG
Intuitive Surgical
1.7$752.01flat$88.40 billion$4.48 billion85.65Earnings Announcement
Becton, Dickinson and logo
BDX
Becton, Dickinson and
2.0$260.24flat$75.69 billion$17.12 billion95.33Dividend Announcement
News Coverage
Edwards Lifesciences logo
EW
Edwards Lifesciences
1.6$85.89flat$53.53 billion$4.35 billion68.71Upcoming Earnings
Boston Scientific logo
BSX
Boston Scientific
2.2$36.78flat$52.67 billion$10.74 billion14.09
IDEXX Laboratories logo
IDXX
IDEXX Laboratories
1.5$489.21flat$41.73 billion$2.41 billion85.23Upcoming Earnings
Baxter International logo
BAX
Baxter International
2.3$80.10flat$40.92 billion$11.36 billion45.51
DexCom logo
DXCM
DexCom
1.9$376.39flat$36.14 billion$1.48 billion155.53Insider Selling
ResMed logo
RMD
ResMed
1.4$221.68flat$32.12 billion$2.96 billion47.57Upcoming Earnings
Hologic logo
HOLX
Hologic
1.9$76.34flat$19.62 billion$3.78 billion18.18Upcoming Earnings
Insulet logo
PODD
Insulet
1.3$288.91flat$19.05 billion$738.20 million656.63
Teleflex logo
TFX
Teleflex
2.0$382.14flat$17.80 billion$2.60 billion49.18
STERIS logo
STE
STERIS
2.1$190.41flat$16.25 billion$3.03 billion38.62Upcoming Earnings
Varian Medical Systems logo
VAR
Varian Medical Systems
1.3$175.33flat$16.02 billion$3.17 billion59.84
Abiomed logo
ABMD
Abiomed
1.5$348.32flat$15.74 billion$840.88 million76.55Upcoming Earnings
Masimo logo
MASI
Masimo
1.4$257.09flat$14.15 billion$937.84 million66.78
Hill-Rom logo
HRC
Hill-Rom
2.0$101.16flat$6.71 billion$2.88 billion30.47
Globus Medical logo
GMED
Globus Medical
1.4$64.44flat$6.36 billion$785.37 million70.04
Integra LifeSciences logo
IART
Integra LifeSciences
1.4$69.36flat$5.85 billion$1.52 billion103.52
NuVasive logo
NUVA
NuVasive
1.5$56.80flat$2.91 billion$1.17 billion-258.18
AtriCure logo
ATRC
AtriCure
1.3$58.30flat$2.62 billion$230.81 million-50.70
Integer logo
ITGR
Integer
2.3$78.15flat$2.57 billion$1.26 billion35.52
Cardiovascular Systems logo
CSII
Cardiovascular Systems
1.3$46.51flat$1.87 billion$236.54 million-70.47
Alphatec logo
ATEC
Alphatec
0.8$14.92flat$1.17 billion$113.43 million-13.56
CryoLife logo
CRY
CryoLife
1.5$24.96flat$969.87 million$276.22 million-65.68
Orthofix Medical logo
OFIX
Orthofix Medical
1.2$44.94flat$868.77 million$459.95 million37.45
AngioDynamics logo
ANGO
AngioDynamics
1.6$18.55flat$704.04 million$264.16 million-4.15
Surmodics logo
SRDX
Surmodics
1.5$46.33flat$633.89 million$94.86 million579.13News Coverage
Accuray logo
ARAY
Accuray
2.2$5.08flat$463.67 million$382.93 million36.29Upcoming Earnings
Invacare logo
IVC
Invacare
1.6$9.92flat$341.43 million$927.96 million-8.06
Rockwell Medical logo
RMTI
Rockwell Medical
1.3$1.46flat$136.62 million$61.30 million-3.40
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.